Heart Failure NYHA Class III Clinical Trial
Official title:
Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure
The ALLEVIATE-HF study is a prospective, randomized, controlled, blinded, multi-site, interventional, investigational device exemption (IDE) pivotal study. The purpose of the study is to demonstrate the safety and efficacy of a patient management pathway that utilizes an integrated device diagnostic-based risk stratification algorithm to guide patient care in subjects with NYHA class II and III heart failure, and to demonstrate the safety of the Reveal LINQ™ system and procedure in the study population.
The study will utilize the market released Reveal LINQ™ Insertable Cardiac Monitor with an investigational ALLEVIATE-HF RAMware download. The study will enroll up to 900 subjects at up to 75 sites in the US. Subjects will be followed until the last enrolled subject is followed for 7 months or until the end of the study, whichever occurs first, or until time of study exit or death as applicable, but no longer than 36 months. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06097481 -
Narrative Intervention for Chronic Illness- Heart Failure Trial (NICI-HF)
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT03005184 -
Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2
|
Phase 2 | |
| Not yet recruiting |
NCT01669395 -
Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial
|
N/A | |
| Completed |
NCT05835063 -
A Study to Improve Physician-Youth Communication and Medical Decision Making
|
N/A | |
| Completed |
NCT03895073 -
HEart fAiluRe evaluaTion Questionnaire
|
||
| Completed |
NCT03095196 -
Multipolar CRT-d and Diabetes
|
N/A | |
| Recruiting |
NCT03180320 -
Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)
|
N/A | |
| Completed |
NCT06233695 -
Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure
|
||
| Withdrawn |
NCT03947853 -
Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure
|
||
| Recruiting |
NCT05934487 -
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
|
N/A | |
| Recruiting |
NCT04829617 -
Promoting Well-being and Health in Heart Failure
|
N/A | |
| Recruiting |
NCT03538990 -
Effect of DASH Eating Pattern on Heart Failure Outcomes
|
N/A | |
| Recruiting |
NCT05487365 -
Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF
|
N/A | |
| Completed |
NCT03592836 -
Diuretic Response in Advanced Heart Failure: Bolus Intermittent vs Continuous INfusion
|
Phase 3 | |
| Completed |
NCT01560871 -
Effects of a Walking Program and Inspiratory Muscle Training in Individuals With Chronic Heart Failure
|
N/A | |
| Completed |
NCT03387813 -
Hemodynamic-GUIDEd Management of Heart Failure
|
N/A | |
| Not yet recruiting |
NCT06270875 -
Addressing Pain Through Navigator-Led Palliative Care Optimized for Heart Failure (ADAPT-HF)
|
N/A | |
| Enrolling by invitation |
NCT05885607 -
Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure
|
||
| Active, not recruiting |
NCT04012944 -
SIRONA 2 Trial Heart Failure NYHA Class III
|
N/A | |
| Recruiting |
NCT05879887 -
An Optimization Pilot to Optimize An Early Palliative Care Intervention for Advanced Heart Failure
|
N/A |